A Phase 3, Randomized, Double-Blind, Cross-Over, Active-

Project: Research project

Description

A Phase 3, Randomized, Double-Blind, Cross-Over, Active-Controlled Study of the Efficacy and Safety of HPN-100, Glyceryl tri-(4-phenylbutyrate), for the Treatment of Adults with Urea Cycle Disorders
StatusFinished
Effective start/end date7/6/096/30/11

Funding

  • Hyperion Therapeutics

Fingerprint

Inborn Urea Cycle Disorder
Safety
glycerol phenylbutyrate
4-phenylbutyric acid